Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Revolutionizing Relief: Conventions Psychiatry & Counseling Partners with Apollo and NeuroStar TMS

Warrenville, IL (Newsworthy.ai) Friday Jan 26, 2024 @ 7:00 AM Eastern —

TMS therapy employs a magnet to stimulate specific nerve cells within the brain responsible for mood control. By targeting these areas, the treatment positively influences neurotransmitter levels, resulting in a reduction in depressive symptoms. Unlike traditional treatments, TMS doesn't involve surgery or medication adjustments, presenting a risk-free alternative for patients.

At Conventions Psychiatry & Counseling, a TMS session ranges from 19 to 37 minutes, designed to be non-disruptive with no impact on alertness or memory. Patients can independently drive to and from sessions. Typically, treatment occurs five days a week for 4-6 weeks, optimizing the potential for successful outcomes.

Covered by most insurances, Conventions TMS Therapy offers an accessible solution for individuals seeking relief from treatment-resistant depression. The therapy provides an evidence-based alternative to medications, instilling new hope for those who haven't found success with traditional treatments.

In collaboration with Apollo and NeuroStar TMS, Conventions Psychiatry & Counseling is dedicated to transforming the lives of individuals suffering from treatment-resistant depression through effective and non-invasive TMS therapy.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Revolutionizing Relief: Conventions Psychiatry & Counseling Partners with Apollo and NeuroStar TMS.



This post first appeared on Newsworthy.ai News Marketing, please read the originial post: here

Share the post

Revolutionizing Relief: Conventions Psychiatry & Counseling Partners with Apollo and NeuroStar TMS

×

Subscribe to Newsworthy.ai News Marketing

Get updates delivered right to your inbox!

Thank you for your subscription

×